For patients with persistent pain after spinal surgery, revision surgery and biologic disc repair each offer distinct trade-offs. This guide explores both options, explaining how intra-annular fibrin injection may address ongoing disc pathology in select FBSS patients—while emphasizing that candidacy and outcomes vary by individual.

For patients with chronic discogenic back pain, biologic disc repair via intra-annular fibrin injection may offer a less invasive alternative to spinal fusion—particularly when annular tears are the primary pain source and conservative care has not provided lasting relief. Candidacy is evaluated individually; outcomes vary by case.

Intra-annular fibrin injection offers a minimally invasive, biologic approach to disc repair for patients with chronic back pain who have not found lasting relief from conservative care. Learn how this regenerative option works, what clinical follow-up data show, and how candidacy is individually evaluated at Valor Spine.

For patients living with persistent back pain after one or more spinal surgeries, intra-annular fibrin injection — a biologic disc repair approach — may offer a meaningful non-surgical path forward. Outcomes vary by individual, and candidacy is determined through a thorough diagnostic evaluation.

Explore eight non-surgical alternatives to spinal fusion for chronic back pain, including biologic disc repair, physical therapy, PRP, and more. Candidacy varies by individual diagnosis and imaging findings.

For patients dealing with chronic back or neck pain, spinal fusion is not the only path forward. A growing range of non-surgical approaches — from biologic disc repair to targeted physical therapy and psychological support — may offer meaningful relief for the right candidates.